Shigella isolates from the global enteric multicenter study inform vaccine development. - Test2 - elhamkhani - TriplyDB

Shigella isolates from the global enteric multicenter study inform vaccine development.

Shigella isolates from the global enteric multicenter study inform vaccine development.

http://www.wikidata.org/entity/Q34202171

about

Shigellosis: Epidemiology in India Cellular Aspects of Shigella Pathogenesis: Focus on the Manipulation of Host Cell Processes The Rising Dominance of Shigella sonnei: An Intercontinental Shift in the Etiology of Bacillary Dysentery Travel- and Community-Based Transmission of Multidrug-Resistant Shigella sonnei Lineage among International Orthodox Jewish Communities Draft genomes of Shigella strains used by the STOPENTERICS consortium Analysis of Shigella flexneri Resistance, Biofilm Formation, and Transcriptional Profile in Response to Bile Salts.Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study.Genome diversity of Shigella boydii.Molecular characterization of Shigella spp. from patients in Gabon 2011-2013.The extant World War 1 dysentery bacillus NCTC1: a genomic analysis.Design and rationale of a matched cohort study to assess the effectiveness of a combined household-level piped water and sanitation intervention in rural Odisha, India Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutants Gastrointestinal infections and diarrheal disease in Ghanaian infants and children: an outpatient case-control study.Shigella outer membrane protein PSSP-1 is broadly protective against Shigella infection.Draft Genome Sequence of 24570, the Type Strain of Shigella flexneri Virulence factors and mechanisms of antimicrobial resistance in Shigella strains from periurban areas of Lima (Peru)Combination vaccines against diarrheal diseases.Species-wide whole genome sequencing reveals historical global spread and recent local persistence in Shigella flexneri Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB Shigella IpaB and IpaD displayed on L. lactis bacterium-like particles induce protective immunity in adult and infant mice.Stx-Producing Shigella Species From Patients in Haiti: An Emerging Pathogen With the Potential for Global Spread Identification and antimicrobial resistance patterns of bacterial enteropathogens from children aged 0-59 months at the University Teaching Hospital, Lusaka, Zambia: a prospective cross sectional study.Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects.Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) reveals highly pure preparations.Shigella Antimicrobial Drug Resistance Mechanisms, 2004-2014.Monoclonal Antibodies to Shigella Lipopolysaccharide Are Useful for Vaccine Production.The First Report of a Fully Sequenced Resistance Plasmid from Shigella boydii.Shigella Vaccine Development: Finding the Path of Least Resistance.Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study.Shigella sonnei Bacteremia Presenting with Profound Hepatic Dysfunction.Multiple etiologies of infectious diarrhea and concurrent infections in a pediatric outpatient-based screening study in Odisha, India.Recent Outbreaks of Shigellosis in California Caused by Two Distinct Populations of Shigella sonnei with either Increased Virulence or Fluoroquinolone Resistance.Environmental transmission of diarrheal pathogens in low and middle income countries.Outer membrane proteins analysis of Shigella sonnei and evaluation of their antigenicity in Shigella infected individuals.In silico analysis to identify vaccine candidates common to multiple serotypes of Shigella and evaluation of their immunogenicity.Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe.The genomic signatures of Shigella evolution, adaptation and geographical spread.Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.Update on: Shigella new serogroups/serotypes and their antimicrobial resistance.The synthesis of OspD3 (ShET2) in Shigella flexneri is independent of OspC1.

P2860

Q26739692-9AED4784-6AD5-496A-9F73-BD218B9743D9 Q26749369-6142FF52-E87D-467C-844E-ADAEDDD2A272 Q26825840-32C3F80A-9E78-49D2-B974-0E5CDB934A3B Q28597463-7ADF3308-56D3-4FBA-B149-0BBEE8DA27CF Q28646046-627D040E-8C7B-474A-89AB-CAE6402D23ED Q30252849-592ECE4E-69D3-4A68-86BA-0CFB44D956F9 Q30275836-8EA1DF66-6D52-43DC-895D-CC6C4FCA1988 Q30277011-2AA22EE5-F378-4978-907D-6A1AE3BF4D65 Q30368857-5466080F-1C61-4DC1-A98A-F9388B06B995 Q30597282-213C3CD5-BDE1-4F47-827E-F5141E15BE8E Q33552828-4C0793A7-6325-4F94-A1F9-6B17085D423F Q34138990-5A253CA0-5AD2-4F58-9818-1A097528648C Q35147903-70337DD8-FB72-47CB-A2F6-96C793291193 Q35221181-8E65D064-76E7-4A28-AE30-3C8C5B80A6C6 Q35662104-7D0A1CCE-F7E7-43BF-A1DB-4AC5DB88CBF6 Q35706366-F9673EB1-A6E6-461E-A6FC-EA4BBE5508DD Q35896237-D2D09B8E-9BD0-42D0-BD20-A81C14AA1B02 Q35909689-7088BFB9-8422-4D81-836A-09EDB56F0B41 Q35924773-56F8416E-6E9B-4B4B-AC03-821E8A673840 Q35946462-D3B9E76D-6623-4937-8B5E-5CD8639A3013 Q36164678-3BAAEDD9-80BA-4545-84AD-19DF9DD9DDEF Q36268162-238CFCA4-9AC1-4001-85CF-E1A52C3FD0FD Q36764372-C22E2D8D-96EE-4AE1-BEF9-518338643E59 Q36765670-C8564DC0-229D-4737-BAE4-950B3F199395 Q36935306-1BB466D3-184D-4488-961A-7E638F72EAD1 Q37163698-2F2A5475-4C0B-43DB-B06B-43665413A823 Q37314114-7512E859-1BA7-4689-B7F8-4F8C6FD90C57 Q37477191-ACEF8087-8E4B-4BDC-8B80-1B8B61209441 Q37477196-46DFA5BC-6867-40EA-91A4-F8134C109BFB Q37689835-642489F6-FF56-4516-9578-9272945F48C2 Q37747766-5E3C23E1-8F28-4676-9AF5-3B637A9221F2 Q38376613-9514AF1F-0255-489C-8A1D-899C6FFDCF84 Q38379063-BC7351D2-411D-423A-881C-7649D812AD37 Q38605714-F8992462-FB10-44C8-AB34-4FFE93F523A2 Q38648043-767BC286-FF64-4DC2-8ACE-6DF7AE02246B Q38665950-0F5D81B7-FEB6-4C3E-BEBA-593F18E29C39 Q38753453-521523CE-4935-477A-945D-90BB40320CFB Q38776163-FE419531-B493-45A4-9310-452287FBDC11 Q38991332-A8B8C883-0AF8-43B9-9435-4453A90E4C71 Q39362868-5B50B771-7866-400F-8CAA-F30223FDCB0D

P2860

Shigella isolates from the global enteric multicenter study inform vaccine development.

http://www.wikidata.org/entity/Q34202171

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Shigella isolates from the global enteric multicenter study inform vaccine development.

@ast

Shigella isolates from the global enteric multicenter study inform vaccine development.

@en

Shigella isolates from the global enteric multicenter study inform vaccine development.

@nl

type

label

Shigella isolates from the global enteric multicenter study inform vaccine development.

@ast

Shigella isolates from the global enteric multicenter study inform vaccine development.

@en

Shigella isolates from the global enteric multicenter study inform vaccine development.

@nl

prefLabel

Shigella isolates from the global enteric multicenter study inform vaccine development.

@ast

Shigella isolates from the global enteric multicenter study inform vaccine development.

@en

Shigella isolates from the global enteric multicenter study inform vaccine development.

@nl

P1433

Q34202171-F399E081-B7D2-4F55-B893-966B47C09851

P1476

Q34202171-BD286B44-43A9-4922-929F-7C9E210C9618

P2093

Q34202171-0C780626-4FF5-475F-8ABD-967A72761EBC

Q34202171-32A2926E-3229-4916-929F-2E899D7CFBE5

Q34202171-359F7416-768E-4B45-AF41-12EE147BE01A

Q34202171-3DB0A57A-AEED-4F47-8AC7-49B9676839F4

Q34202171-3F3C6B64-7E30-41BC-A0C8-A665EEAF11D8

Q34202171-529A1D62-EB74-407A-A34E-79DF4A8A15D9

Q34202171-541713D1-96E8-46BF-A364-7E71A00D890F

Q34202171-563999E3-16AE-4927-B663-893363199C4E

Q34202171-64F9E4AE-60B2-4592-9E8C-14017AC1D469

Q34202171-742ACFD3-D514-4049-AC86-07A9B8232C9D

P2860

Q34202171-08A9A9BD-919D-46A2-BE21-7258C96C30D7

Q34202171-1B151F8A-5860-47EA-B37F-6B1524F76C21

Q34202171-1C65BCC3-9C47-43EC-832F-7D037CF3A6C4

Q34202171-1D01879A-23BD-4957-BD8B-85962C040966

Q34202171-1EE085E3-99B6-4948-B6AC-F5087B1ED9D6

Q34202171-269871BF-7B6B-4BB0-B12A-16C7962969C3

Q34202171-30BC21E9-BD33-4238-B21A-39BD101BC2FD

Q34202171-31B93450-668E-40AD-B85F-A48E2F7BC237

Q34202171-39586F79-E52B-4E71-A7C6-7B6FABE56BEB

Q34202171-3A6CB24F-E5AF-4F00-8762-8A74B622B3B1

P304

Q34202171-964CF572-9F19-4F95-94B1-5634E5EAE305

P31

Q34202171-28413436-BD8A-47F1-A6BE-AC16D32F5B6B

P356

Q34202171-AC2EE8D3-AFAB-41C4-A8C0-6B54FDA81F35

P407

Q34202171-D3CFDDE4-8614-47DF-A945-9FDF86BBB0B7

P433

Q34202171-5E926C49-F4CC-440E-A22C-F0CA7510C723

P478

Q34202171-57A10C6B-6708-4F30-9445-D42775A694A5

P50

Q34202171-1C39DA39-40E5-442E-AD05-E53FBAF80DCA

Q34202171-20D46D76-99B9-4776-BAE4-5472C5805B21

Q34202171-3957543F-4115-4485-BCCA-76AB15EA77B1

Q34202171-48DC78AF-3854-45A2-A131-4303E68EE7D0

Q34202171-84AFCF68-DDEC-48AB-B4C7-751F522B58FD

Q34202171-8C8FC631-AE30-468C-845C-AE6C6CA776CA

Q34202171-913CF129-0941-468D-AEB7-5D4DFF12727B

Q34202171-B1ADD928-E880-4BF8-88CE-FEE5DA9A244A

Q34202171-BA9359C0-2DE7-4A26-B349-8FB0D7B00872

Q34202171-BDEB5C9D-0A12-4B43-9786-DB750ED13A2C

P577

Q34202171-6A6FCEB8-6AAF-4EC7-BC9D-F96BC36604E8

P5875

Q34202171-33E1C6A0-EB14-48AD-B1AD-6CAB38AEC8F9

P698

Q34202171-DCEC3284-57ED-43D7-B021-F6EEBE8EDFA4

P921

Q34202171-B1CE60D8-5CEC-432C-9D57-59E74071305C

P932

Q34202171-26CA2F4C-F4F7-4B40-AC4C-26DC4E8CB46C

P356

P1433

Clinical Infectious Diseases

P1476

Shigella isolates from the global enteric multicenter study inform vaccine development.

@en

P2093

Abu Syed Golam Faruque

http://www.w3.org/2001/XMLSchema#string

Anita K M Zaidi

http://www.w3.org/2001/XMLSchema#string

Anowar Hossain

http://www.w3.org/2001/XMLSchema#string

Ciara E O'Reilly

http://www.w3.org/2001/XMLSchema#string

Dani Cohen

http://www.w3.org/2001/XMLSchema#string

Debasish Saha

http://www.w3.org/2001/XMLSchema#string

Dilruba Nasrin

http://www.w3.org/2001/XMLSchema#string

Dipika Sur

http://www.w3.org/2001/XMLSchema#string

Eileen M Barry

http://www.w3.org/2001/XMLSchema#string

Eric D Mintz

http://www.w3.org/2001/XMLSchema#string

P2860

A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology

Quantitative PCR for detection of Shigella improves ascertainment of Shigella burden in children with moderate-to-severe diarrhea in low-income countries

Housefly population density correlates with shigellosis among children in Mirzapur, Bangladesh: a time series analysis

Some epidemiologic, clinical, microbiologic, and organizational assumptions that influenced the design and performance of the Global Enteric Multicenter Study (GEMS).

The Global Enteric Multicenter Study (GEMS): impetus, rationale, and genesis.

Diagnostic microbiologic methods in the GEMS-1 case/control study.

A household survey of dysentery in Burundi: implications for the current pandemic in sub-Saharan Africa.

Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo

Evolutionary genetics of a new pathogenic Escherichia species: Escherichia albertii and related Shigella boydii strains

Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602

P304

933-941

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIU468

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

Myron M. Levine

Pedro L. Alonso

Robert F Breiman

Boubou Tamboura

John Benjamin Ochieng

Shahida Qureshi

Inacio Mandomando

Karen L Kotloff

P577

2014-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264633221

http://www.w3.org/2001/XMLSchema#string

P698

24958238

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

4166982

http://www.w3.org/2001/XMLSchema#string